Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 History  





2 Modified mechanisms  





3 Legal status  





4 See also  





5 References  














MON 863: Difference between revisions






Dansk
Français
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 




Print/export  



















Appearance
   

 





Help
 

From Wikipedia, the free encyclopedia
 


Browse history interactively
 Previous editNext edit 
Content deleted Content added
Markmark206 (talk | contribs)
12 edits
AnomieBOT (talk | contribs)
6,331,754 edits
m Dating maintenance tags: {{Citation needed}}
Line 12: Line 12:


==Legal status==

==Legal status==

MON 863 is approved for use in [[Australia]], [[Canada]], [[China]], the [[European Union]], [[Japan]], [[Mexico]], [[New Zealand]], the [[Philippines]], [[Russia]], [[Singapore]], [[South Korea]], [[Taiwan]], and the [[United States]].{{Citation needed}}

MON 863 is approved for use in [[Australia]], [[Canada]], [[China]], the [[European Union]], [[Japan]], [[Mexico]], [[New Zealand]], the [[Philippines]], [[Russia]], [[Singapore]], [[South Korea]], [[Taiwan]], and the [[United States]].{{Citation needed|date=August 2013}}



==See also==

==See also==


Revision as of 09:21, 29 August 2013

MON 863 is a genetically engineered variety of maize produced by Monsanto.

History

In 2004, Monsanto sought approval in Europe to introduce MON 863. Approval was granted in 2005 for use in feed[1] and in 2006 for use in food.[2] There was controversy over acceptance by regulatory bodies of industry-funded toxicity studies and over the design of those studies led by Pr Gilles-Éric Séralini, who was on the committee that reviewed MON863 for the French government,[3]

See Genetically modified food controversies for details of this controversy, which extended beyond MON 863.

Following legal action by parties including the Swedish Board of Agriculture and Greenpeace, a Münster appeals court ruled that Monsanto would be forced to publicly reveal its research data.[4]

Modified mechanisms

MON 863 is genetically altered to express a modified version of Cry3Bb1, a delta endotoxin which originates from Bacillus thuringiensis.[5][6] This protects the plant from corn rootworm.[6][7] Unlike MON 810, Bt 11, and Bt 176 which each produce a modified Cry1Ab, MON 863 instead produces a modified Cry3Bb1 toxin and contains nptII, a marker gene for antibiotic resistance.[5][8]

Legal status

MON 863 is approved for use in Australia, Canada, China, the European Union, Japan, Mexico, New Zealand, the Philippines, Russia, Singapore, South Korea, Taiwan, and the United States.[citation needed]

See also

References

  • ^ Seralini bio on CRIIGEN
  • ^ Reilly, Michael (2010-01-23). "Is Genetically Modified Corn Toxic?". Discovery News. Retrieved 2010-07-21.
  • ^ a b "The MON863 case - a chronicle of systematic deception" (PDF). Greenpeace. Retrieved 2010-07-22. MON863 is a genetically modified corn that expresses a Bt-toxin. This toxin is a modified version of the delta endotoxin Cry3Bb1 which originates from the microorganism Bacillus thuringiensis. The genetic manipulation is aimed at protecting maize plants against a pest called corn rootworm (Diabrotica spp.). MON863 differs from other Bt-corns already placed on the market (MON810, BT11, Bt176), which produce a modified Cry1Ab toxin conferring resistance to a pest called European corn borer (Ostrinia nubilalis), in that it produces an artificial Cry3Bb1 toxin. In addition to the modified Cry3Bb1 toxin gene MON863 contains an antibiotic resistance marker gene.
  • ^ a b Doull, J.; Gaylor, D.; Greim, H.A.; Lovell, D.P.; Lynch, B.; Munro, I.C. (2007). "Report of an Expert Panel on the reanalysis by of a 90-day study conducted by Monsanto in support of the safety of a genetically modified corn variety (MON 863)". Food and Chemical Toxicology. 45 (11): 2073–85. doi:10.1016/j.fct.2007.08.033. PMID 17900781.
  • ^ Coghlan, Andy (2010-01-22). "Engineered maize toxicity claims roundly rebuffed". New Scientist. Retrieved 2010-07-21.
  • ^ Lorch, Antje (2005-09-30). "EFSA's Opinion on MON863 hybrids" (PDF). ifrik. Greenpeace. Retrieved 2010-07-22. MON863 contains an GM antibiotic resistance gene (nptII) against kanamycin and neomycin.

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=MON_863&oldid=570647381"

    Categories: 
    Genetically modified maize
    Monsanto
    Hidden categories: 
    All articles with unsourced statements
    Articles with unsourced statements from August 2013
     



    This page was last edited on 29 August 2013, at 09:21 (UTC).

    This version of the page has been revised. Besides normal editing, the reason for revision may have been that this version contains factual inaccuracies, vandalism, or material not compatible with the Creative Commons Attribution-ShareAlike License.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki